We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.14B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$2.19B
AUM Growth
+$209M
Cap. Flow
+$49.6M
Cap. Flow %
2.27%
Top 10 Hldgs %
52.18%
Holding
33
New
1
Increased
24
Reduced
8
Closed
–

Top Buys

1
GILD icon
Gilead Sciences
GILD
+$8.75M
2
QCOM icon
Qualcomm
QCOM
+$7.24M
3
EL icon
Estee Lauder
EL
+$6.02M
4
BIIB icon
Biogen
BIIB
+$5.55M
5
EMC
EMC CORPORATION
EMC
+$4.02M

Top Sells

1
CELG
Celgene Corp
CELG
+$4.84M
2
CPRI icon
Capri Holdings
CPRI
+$1.71M
3
CVS icon
CVS Health
CVS
+$482K
4
IWV icon
iShares Russell 3000 ETF
IWV
+$10.6K
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$8.23K

Sector Composition

1 Healthcare 30.23%
2 Consumer Discretionary 24.87%
3 Technology 24.51%
4 Consumer Staples 10.1%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
$120M 5.47%
1,414,460
+4,966
+0.4% +$388K
CVS icon
2
CVS Health
CVS
$136B
$118M 5.41%
1,228,750
-5,472
-0.4% -$482K
CELG
3
DELISTED
Celgene Corp
CELG
$118M 5.37%
1,050,581
-45,861
-4% -$4.84M
COST icon
4
Costco
COST
$419B
$116M 5.31%
819,841
+1,420
+0.2% +$193K
ORCL icon
5
Oracle
ORCL
$358B
$116M 5.29%
2,574,188
+13,827
+0.5% +$563K
TJX icon
6
TJX Companies
TJX
$171B
$115M 5.23%
3,341,144
+42,940
+1% +$1.37M
JWN
7
DELISTED
Nordstrom
JWN
$114M 5.2%
1,432,449
+21,146
+1% +$1.55M
AAPL icon
8
Apple
AAPL
$4.89T
$110M 5.01%
3,970,324
+42,904
+1% +$1.17M
NKE icon
9
Nike
NKE
$66.1B
$109M 4.96%
2,258,444
+48,882
+2% +$2.29M
HCA icon
10
HCA Healthcare
HCA
$85.6B
$108M 4.93%
1,470,687
+34,253
+2% +$2.41M
DIS icon
11
Walt Disney
DIS
$173B
$108M 4.93%
1,145,326
+34,586
+3% +$3.12M
ADBE icon
12
Adobe
ADBE
$93.5B
$107M 4.88%
1,468,672
+33,528
+2% +$2.35M
EBAY icon
13
eBay
EBAY
$49.2B
$106M 4.85%
4,497,889
+154,666
+4% +$3.51M
CMCSA icon
14
Comcast
CMCSA
$86.1B
$106M 4.84%
3,653,126
+103,940
+3% +$2.85M
EL icon
15
Estee Lauder
EL
$30B
$105M 4.79%
1,376,661
+81,440
+6% +$6.02M
BIIB icon
16
Biogen
BIIB
$30.8B
$104M 4.75%
306,232
+17,170
+6% +$5.55M
QCOM icon
17
Qualcomm
QCOM
$180B
$103M 4.69%
1,380,076
+98,904
+8% +$7.24M
EMC
18
DELISTED
EMC CORPORATION
EMC
$102M 4.65%
3,424,133
+137,989
+4% +$4.02M
CPRI icon
19
Capri Holdings
CPRI
$1.94B
$101M 4.63%
1,348,957
-22,931
-2% -$1.71M
GILD icon
20
Gilead Sciences
GILD
$169B
$94.1M 4.3%
998,039
+84,641
+9% +$8.75M
SPY icon
21
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$4.28M 0.2%
20,805
+15,958
+329% +$3.21M
VEU icon
22
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$1.59M 0.07%
33,895
+298
+0.9% +$14.3K
XLY icon
23
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
$1.1M 0.05%
30,366
+1,380
+5% +$47.3K
VGT icon
24
Vanguard Information Technology ETF
VGT
$139B
$1.01M 0.05%
77,632
-544
-0.7% -$6.94K
XLV icon
25
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$866K 0.04%
12,662
-123
-1% -$8.23K
1
2

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $4.12B AUM
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return

WestEnd Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, WestEnd Advisors held 33 positions worth $2.19B, up 11% from $1.98B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 3%. WestEnd Advisors opened 1 new position and made no exits, leaving the 33-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Technology.

  • WestEnd Advisors's largest Q4 2014 buy was iShares Core S&P 500 ETF: 361 shares worth $74.7K.
  • WestEnd Advisors added most to Gilead Sciences in Q4 2014, an estimated $8.75M increase.
  • WestEnd Advisors's biggest Q4 2014 reduction was Celgene Corp, cutting an estimated $4.84M.
  • WestEnd Advisors's ten largest holdings make up 52% of its $2.19B portfolio in Q4 2014.
  • WestEnd Advisors opened 1 new position and closed 0 in Q4 2014.
  • WestEnd Advisors's portfolio value rose 11% quarter-over-quarter to $2.19B.

Based on WestEnd Advisors's 13F filing for Q4 2014, filed 5 Feb 2015.